Moreover, smaller genomic deletions and de novo single-nucleotide variants have been identified that specifically link Top3β mutations to schizophrenia, autism, epilepsy, intellectual disability, and cognitive impairment3,4,7–10. This evidence concerns the gene TOP3B and schizophrenia.